Mélanie Buchi

548 total citations
6 papers, 224 citations indexed

About

Mélanie Buchi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mélanie Buchi has authored 6 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Mélanie Buchi's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Mélanie Buchi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Mélanie Buchi collaborates with scholars based in Switzerland, Chile and Germany. Mélanie Buchi's co-authors include Alfred Zippelius, Abhishek S. Kashyap, Philipp Müller, Lucia D’Amico, Heinz Läubli, Tamara Hell, Roger R. Beerli, Ulrike Menzel, Radek Špíšek and Tatjana Vlajnic and has published in prestigious journals such as Frontiers in Oncology, Cancer Immunology Immunotherapy and Cancer Immunology Research.

In The Last Decade

Mélanie Buchi

5 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mélanie Buchi Switzerland	5	133	92	67	34	30	6	224
Juan‐Manuel Hernandez‐Martinez Mexico	6	168 1.3×	164 1.8×	71 1.1×	10 0.3×	68 2.3×	13	318
Maria McSharry United States	5	129 1.0×	157 1.7×	141 2.1×	11 0.3×	49 1.6×	8	330
Laia Muixí Spain	8	32 0.2×	60 0.7×	84 1.3×	16 0.5×	23 0.8×	11	191
Joseph Tintelnot Germany	9	131 1.0×	57 0.6×	73 1.1×	29 0.9×	58 1.9×	18	220
Heidi M. Haikala Finland	7	131 1.0×	24 0.3×	212 3.2×	39 1.1×	36 1.2×	15	309
Li-Huan Zhou China	7	111 0.8×	121 1.3×	200 3.0×	10 0.3×	42 1.4×	8	362
Carlos E. Espinoza United States	5	105 0.8×	119 1.3×	116 1.7×	5 0.1×	29 1.0×	13	266
Edgar Montes-Servín Mexico	7	171 1.3×	196 2.1×	58 0.9×	7 0.2×	42 1.4×	15	324
Rikke B. Holmstroem Denmark	6	197 1.5×	143 1.6×	61 0.9×	5 0.1×	21 0.7×	10	280
Adam B. Sendor United States	3	134 1.0×	161 1.8×	130 1.9×	9 0.3×	53 1.8×	4	322

Countries citing papers authored by Mélanie Buchi

Since Specialization

Citations

This map shows the geographic impact of Mélanie Buchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Buchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Buchi more than expected).

Fields of papers citing papers by Mélanie Buchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Buchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Buchi. The network helps show where Mélanie Buchi may publish in the future.

Co-authorship network of co-authors of Mélanie Buchi

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Buchi. A scholar is included among the top collaborators of Mélanie Buchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Buchi. Mélanie Buchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Zingg, Andreas, Reto Ritschard, Helen Thut, et al.. (2025). Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors. Cancer Immunology Research. 13(7). 990–1003.

2.

Cianciaruso, Chiara, Ruben Bill, Marcel P. Trefny, et al.. (2023). Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. Journal for ImmunoTherapy of Cancer. 11(5). e006714–e006714. 14 indexed citations

3.

Natoli, Marina, Petra Herzig, Mélanie Buchi, et al.. (2021). Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity. Frontiers in Oncology. 11. 644608–644608. 28 indexed citations

4.

D’Amico, Lucia, Ulrike Menzel, Michael Prummer, et al.. (2019). A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer. Journal for ImmunoTherapy of Cancer. 7(1). 16–16. 89 indexed citations

5.

Kashyap, Abhishek S., Richard Klar, Sandra M. Kallert, et al.. (2019). Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity. Journal for ImmunoTherapy of Cancer. 7(1). 67–67. 51 indexed citations

6.

Läubli, Heinz, Philipp Müller, Lucia D’Amico, et al.. (2018). The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models. Cancer Immunology Immunotherapy. 67(5). 815–824. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact